NAC457.587. Restrictions on donated cancer drugs.

     1. In addition to the requirements of NRS 457.450, a cancer drug that is donated to the Program:

     (a) Must not be a controlled substance.

     (b) Must not be a compounded drug product.

     (c) Must not be dispensed by a pharmacist if the pharmacist suspects that the cancer drug is adulterated or misbranded.

     (d) Must not be dispensed by a pharmacist if, in the professional judgment of the pharmacist, there is a reasonable concern relating to the safety or efficacy of the cancer drug.

     (e) Must not require refrigeration or freezing or other temperature requirements that are not a controlled room temperature.

     (f) Must not be a cancer drug for which a program of restrictive distribution has been established by the manufacturer of the cancer drug.

     (g) Must not be a cancer drug for which an ongoing clinical trial or study is being conducted.

     (h) Must be a cancer drug that was dispensed pursuant to an original prescription by a pharmacy licensed pursuant to chapter 639 of NRS.

     2. As used in this section, “program of restrictive distribution” means a program that is developed in collaboration with the United States Food and Drug Administration by a manufacturer of a drug to reduce the risks associated with that drug by limiting the persons who can prescribe the drug and who can receive the drug.

     (Added to NAC by Bd. of Pharmacy by R211-09, eff. 7-22-2010)